Perioperative β-blocker therapy has been advocated to reduce cardiac mortality and
morbidity in high-risk cardiac patients undergoing non-cardiac surgery. Core data that …

The cardiology literature has suggested for decades that β-blockade protects patients with
ischaemic heart disease. Extending this concept to perioperative patients initially produced …

Discussion The guideline on perioperative β-blockade is a valuable update on an issue
about which conflicting perspectives exist, especially considering the controversy …

Beta-adrenergic blockers (β-blockers) are clearly indicated for the long-term treatment of
patients with systolic heart failure and post-acute myocardial infarction. Early small-scale …

In their meta-analysis on the effects of β blockers in patients undergoing non-cardiac
surgery, Sripal Bangalore and colleagues (Dec 6, p 1962) 1 seem to disregard the important …

Purpose Our aim was to analyze the current scientific literature relevant to the use of β-
adrenergic receptor antagonists for the prevention of cardiovascular morbidity and mortality …

ContextRecent studies suggest that perioperatively administered β-blockers may reduce the
risk of adverse cardiac events in patients undergoing major noncardiac surgery. ObjectiveTo …

Background Current guidelines on perioperative care recommend the prophylactic use of β
blockers in high-risk patients undergoing noncardiac surgery. However, recent studies show …

Based on landmark trials, international guidelines had for years promoted the use of beta-
blockers in the setting of non-cardiac surgery. In 2011, concerns were raised regarding the …

Over the past several decades, medical and surgical knowledge has advanced by leaps and
bounds. This advance in collective knowledge has increased the use of surgical intervention …